title: Artificial tears inhibit the development of experimental immune-mediated blepharoconjunctivitis.
abstract: OBJECTIVE
  To investigate whether treatment with artificial tears inhibits the development of experimental immune-mediated blepharoconjunctivitis (EC).
  
  
  METHODS
  Brown Norway rats were immunized with ovalbumin (OVA) or ragweed (RW) emulsified in complete Freund's adjuvant. Fourteen days after immunization, the rats were challenged with the same antigen (Ag) in eye drops. Treated rats were administered artificial tears by eye drops immediately after, 15 min after, or 30 min after the Ag challenge. Treatment doses of 2, 4, or 8 drops per eye were evaluated. Twenty-four hours after the Ag challenge, the rats were killed and their eyes were harvested for histological studies.
  
  
  RESULTS
  Treatment with artificial tears immediately after and 15 min after challenge with partially insoluble RW Ag suppressed infiltration of inflammatory cells into the conjunctiva. Inhibition was not observed at any time following challenge with OVA Ag, which is a soluble protein. The treatment dose of artificial tears administered did not affect the extent of inhibition of EC following challenge with either Ag.
  
  
  CONCLUSIONS
  Treatment with artificial tears by eye drops inhibited the development of EC induced by the partially insoluble RW Ag when administered within 15 min of the Ag challenge.
authors.affiliation: Department of Ophthalmology, Kochi Medical School, Nankoku 783-8505, Japan. fukusima@med.kochi-u.ac.jp
authors.forename: Atsuki
authors.initials: A
authors.lastname: Fukushima
authors.forename: Olga
authors.initials: O
authors.lastname: Zinchuk
authors.forename: Hisayuki
authors.initials: H
authors.lastname: Ueno
mesh_terms: D031164:Ambrosia / Q000009:adverse effects; D000818:Animals; D001762:Blepharitis / Q000276:immunology / Q000517:prevention & control*; D003233:Conjunctivitis, Allergic / Q000276:immunology / Q000517:prevention & control*; D004195:Disease Models, Animal; D008297:Male; D009883:Ophthalmic Solutions / Q000008:administration & dosage*; D010047:Ovalbumin / Q000008:administration & dosage / Q000009:adverse effects; D051381:Rats; D011914:Rats, Inbred BN
chemical_list: D009883:Ophthalmic Solutions; D010047:Ovalbumin